RNAC
Cartesian Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.27
+1.64%Leverage
- Debt / equity
- -0.51x
- Net debt / equity
- 0.67x
- Debt / assets
- 0.20x
- Debt / EBITDA
- -0.41x
- Net debt / EBITDA
- 0.53x
Liquidity & coverage
- Current ratio
- 7.48x
- Quick ratio
- 7.48x
- Cash ratio
- 7.18x
- Interest coverage
- -115.80x
- EBITDA / interest
- -184.98x
- Working capital
- $133.1M
Cash & dividend
- FCF / debt
- -1.22x
- Cash flow / debt
- -1.19x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026